Cochlear Net Income Over Time
| OC5 Stock | EUR 119.64 0.50 0.42% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Cochlear Performance and Cochlear Correlation. Cochlear |
Cross Equities Net Income Analysis
Compare Cochlear Limited and related stocks such as Cerence, TELES Informationstech, and BIOTIME Net Income Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0S6 | 98.3 M | 98.3 M | 98.3 M | 98.3 M | 98.3 M | 98.3 M | 98.3 M | 98.3 M | 98.3 M | (18.3 M) | 45.9 M | (310.8 M) | (56.3 M) | (588.1 M) | (18.7 M) | (16.8 M) | (17.7 M) |
| TLIK | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 521 K | (3 M) | 3.9 M | 824.5 K | 267.5 K | (1.7 M) | (1.9 M) | (835.2 K) | (751.7 K) | (714.1 K) |
| BT3 | 33.6 M | 33.6 M | 33.6 M | 33.6 M | 33.6 M | 33.6 M | 33.6 M | (20 M) | (46 M) | (11.7 M) | (20.6 M) | (43 M) | (26.3 M) | (21.5 M) | (18.6 M) | (16.7 M) | (17.6 M) |
| MS9 | (487 B) | (487 B) | (487 B) | (487 B) | (155 B) | (758.1 B) | (197.4 B) | (289.3 B) | (228.1 B) | (75.3 B) | (200.1 B) | (181.9 B) | (244.7 B) | (274.8 B) | (116.7 B) | (134.2 B) | (140.9 B) |
| IB5A | (312.8 M) | (312.8 M) | (312.8 M) | (312.8 M) | (312.8 M) | (312.8 M) | (312.8 M) | (362.8 M) | (455.6 M) | (397 M) | (275.4 M) | (363.7 M) | (885.7 M) | (589.3 M) | (553.3 M) | (498 M) | (522.9 M) |
| MBJ | (338 M) | (338 M) | (338 M) | (338 M) | (338 M) | (338 M) | (338 M) | (1.6 B) | (296 M) | (359 M) | (578 M) | (445 M) | (203 M) | (487 M) | (444 M) | (510.6 M) | (536.1 M) |
| MBJ | (338 M) | (338 M) | (338 M) | (338 M) | (338 M) | (338 M) | (338 M) | (1.6 B) | (296 M) | (359 M) | (578 M) | (445 M) | (203 M) | (487 M) | (444 M) | (510.6 M) | (536.1 M) |
| TZO | (778 K) | (778 K) | (778 K) | (778 K) | (1 M) | (9.6 M) | (2.2 M) | (1.3 M) | (1 M) | (297.6 K) | (654.9 K) | (1.3 M) | (2 M) | (1.2 M) | (1 M) | (1.2 M) | (1.3 M) |
| AJW | (4.8 B) | (4.8 B) | (4.8 B) | (4.8 B) | (4.8 B) | (4.8 B) | (4.8 B) | (3.8 B) | (3 B) | (3.8 B) | (4.2 B) | (13.7 B) | (14.7 B) | (7.4 B) | (28.1 B) | (25.3 B) | (24.1 B) |
| 9R5 | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (19.2 M) | (12.2 M) | (10.2 M) | (9.2 M) | (9.6 M) |
Cochlear Limited and related stocks such as Cerence, TELES Informationstech, and BIOTIME Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Cochlear Limited financial statement analysis. It represents the amount of money remaining after all of Cochlear Limited operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Cochlear Limited | OC5 |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 1 University Avenue, |
| Exchange | Frankfurt Exchange |
EUR 119.64
Other Information on Investing in Cochlear Stock
Cochlear financial ratios help investors to determine whether Cochlear Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cochlear with respect to the benefits of owning Cochlear security.